Corporate News 02-Jan-18
Marksans Pharma announces resignation of director
With effect from 02 January 2018
Marksans Pharma announced that Naresh Balwant Wadhwa (DIN: 01999073), has resigned as a Director of the Company with effect from 2 January, 2018.
Previous News
Marksans Pharma consolidated net profit declines 4.44% in the March 2024 quarter
( Results - Announcements 30-May-24 12:46 )
Marksans Pharma gets EIR from USFDA for Goa facility
( Hot Pursuit - 20-Aug-24 14:48 )
Marksans Pharma to conduct board meeting
( Corporate News - 02-Feb-22 10:54 )
Marksans Pharma to convene AGM
( Corporate News - 20-Aug-24 10:46 )
Marksans Pharma AGM scheduled
( Corporate News - 04-Aug-23 11:09 )
Board of Marksans Pharma recommends final dividend
( Corporate News - 31-May-22 19:13 )
eClerx Services Ltd leads gainers in 'A' group
( Hot Pursuit - 11-Jun-21 12:00 )
Marksans Pharma consolidated net profit rises 19.54% in the December 2019 quarter
( Results - Announcements 11-Feb-20 15:11 )
Lincoln Pharmaceuticals Ltd Surges 5.79%
( Hot Pursuit - 11-May-21 09:30 )
Marksans Pharma to hold board meeting
( Corporate News - 11-Jun-21 12:27 )
Marksans Pharma to conduct AGM
( Corporate News - 29-Aug-19 17:02 )
Other Stories
GAIL (India) signs MoU with AM Green
04-Oct-24 19:27
EaseMyTrip.com resumes bookings to the Maldives
04-Oct-24 19:25
BLS completes acquisition of Dubai-based Citizenship Invest
04-Oct-24 19:23
Insecticides India launches new maize herbicide 'Torry Super'
04-Oct-24 19:21
Landmark Cars receives LoI from Mercedes-Benz India
04-Oct-24 19:19
Astra Microwave Products receives affirmation in credit ratings from CRISIL
04-Oct-24 19:16
Supreme Petrochem receives affirmation in credit ratings
04-Oct-24 19:10
Astec LifeSciences director resigns
04-Oct-24 19:08
Board of Gravita India approves change in directorate
04-Oct-24 19:05
Board of Gravita India approves fund raising up to Rs 1,000 cr
04-Oct-24 19:03
Back
Top
